BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 26075454)

  • 1. Inhibition of Rho-Associated Kinase Prevents Pathological Wound Healing and Neovascularization After Corneal Trauma.
    Sijnave D; Van Bergen T; Castermans K; Kindt N; Vandewalle E; Stassen JM; Moons L; Stalmans I
    Cornea; 2015 Sep; 34(9):1120-9. PubMed ID: 26075454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
    Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rho kinase inhibitor AMA0526 improves surgical outcome in a rabbit model of glaucoma filtration surgery.
    Van de Velde S; Van Bergen T; Vandewalle E; Kindt N; Castermans K; Moons L; Stalmans I
    Prog Brain Res; 2015; 220():283-97. PubMed ID: 26497796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasudil hydrochloride, a potent ROCK inhibitor, inhibits corneal neovascularization after alkali burns in mice.
    Zeng P; Pi RB; Li P; Chen RX; Lin LM; He H; Zhou SY
    Mol Vis; 2015; 21():688-98. PubMed ID: 26120273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization.
    Zhou AY; Bai YJ; Zhao M; Yu WZ; Li XX
    Ophthalmic Res; 2013; 50(3):180-6. PubMed ID: 24008241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the intermediate-conductance Ca(2+)-activated K+ channel inhibits the angiogenesis induced by epidermal growth factor in the treatment of corneal alkali burn.
    Yang H; Li X; Ma J; Lv X; Zhao S; Lang W; Zhang Y
    Exp Eye Res; 2013 May; 110():76-87. PubMed ID: 23482085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of β-1,3-glucan isolated from Euglena gracilis on corneal epithelial cell migration and on wound healing in a rat alkali burn model.
    Choi JA; Oh TH; Choi JS; Chang DJ; Joo CK
    Curr Eye Res; 2013 Dec; 38(12):1207-13. PubMed ID: 23841526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone.
    Hoffart L; Matonti F; Conrath J; Daniel L; Ridings B; Masson GS; Chavane F
    Clin Exp Ophthalmol; 2010 May; 38(4):346-52. PubMed ID: 21077280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro.
    Huang T; Zhang K; Sun L; Xue X; Zhang C; Shu Z; Mu N; Gu J; Zhang W; Wang Y; Zhang Y; Zhang W
    Drug Des Devel Ther; 2015; 9():2485-99. PubMed ID: 25995620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nicotine on corneal wound healing following acute alkali burn.
    Kim JW; Lim CW; Kim B
    PLoS One; 2017; 12(6):e0179982. PubMed ID: 28644870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine lactoferrin stimulates human corneal epithelial alkali wound healing in vitro.
    Pattamatta U; Willcox M; Stapleton F; Cole N; Garrett Q
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1636-43. PubMed ID: 19060270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro inhibitory effect of amniotic extraction on neovascularization.
    Jiang A; Li C; Gao Y; Zhang M; Hu J; Kuang W; Hao S; Yang W; Xu C; Gao G; Wang Z; Liu Z
    Cornea; 2006 Dec; 25(10 Suppl 1):S36-40. PubMed ID: 17001191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of oral doxycycline on neovascularization in a rat corneal alkali burn model of angiogenesis.
    Dan L; Shi-long Y; Miao-li L; Yong-ping L; Hong-jie M; Ying Z; Xiang-gui W
    Curr Eye Res; 2008 Aug; 33(8):653-60. PubMed ID: 18696340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxycycline enhances the inhibitory effects of bevacizumab on corneal neovascularization and prevents its side effects.
    Su W; Li Z; Li Y; Lin M; Yao L; Liu Y; He Z; Wu C; Liang D
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9108-15. PubMed ID: 22039247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin ameliorates corneal injury after alkali burn through methylation modification in mouse TSC1 and mTOR genes.
    Li J; Du S; Shi Y; Han J; Niu Z; Wei L; Yang P; Chen L; Tian H; Gao L
    Exp Eye Res; 2021 Feb; 203():108399. PubMed ID: 33352197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine lactoferrin promotes corneal wound healing and suppresses IL-1 expression in alkali wounded mouse cornea.
    Pattamatta U; Willcox M; Stapleton F; Garrett Q
    Curr Eye Res; 2013 Nov; 38(11):1110-7. PubMed ID: 23898919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-β1/ERK pathways regulation.
    Shin YJ; Hyon JY; Choi WS; Yi K; Chung ES; Chung TY; Wee WR
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4452-8. PubMed ID: 23716625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured lipid carriers containing rapamycin for prevention of corneal fibroblasts proliferation and haze propagation after burn injuries: In vitro and in vivo.
    Zahir-Jouzdani F; Khonsari F; Soleimani M; Mahbod M; Arefian E; Heydari M; Shahhosseini S; Dinarvand R; Atyabi F
    J Cell Physiol; 2019 Apr; 234(4):4702-4712. PubMed ID: 30191977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The wound healing effects of vitamin A eye drops after a corneal alkali burn in rats.
    Kim EC; Kim TK; Park SH; Kim MS
    Acta Ophthalmol; 2012 Nov; 90(7):e540-6. PubMed ID: 23106861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2.
    Mochimaru H; Usui T; Yaguchi T; Nagahama Y; Hasegawa G; Usui Y; Shimmura S; Tsubota K; Amano S; Kawakami Y; Ishida S
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2172-7. PubMed ID: 18263815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.